CAR T Cells Produced in vivo to Treat Cardiac InjuryJoel G. Rurik, Jonathan A. Epstein, István Tombácz et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2023Cited by 940
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPsIstván Tombácz, Hamideh Parhiz, Dorottya Laczkó et al.|Molecular Therapy|2021Cited by 272
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic TropismMargaret M. Billingsley, Michael J. Mitchell, Xuexiang Han et al.|Small|2023Cited by 216
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic strokeJia Nong, Oscar A. Marcos‐Contreras, Patrick M. Glassman et al.|Molecular Therapy|2024Cited by 83
IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translationCaitlin M. Tilsed, Hamideh Parhiz, Barzan A. Sadiq et al.|Proceedings of the National Academy of Sciences|2024Cited by 49